Overexpression of MCP‐1 has been shown to enhance microgliosis, facilitate amyloid plaque formation, and accelerate cognitive decline in rodent models of AD (Kiyota et al., 2009; Yamamoto et al., 2005). This evidence concerns the gene CCL2 and Alzheimer disease.